Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Infectious Disease _ Influenza_Avian Flu, H1N1, H5N1, H5N2
Leyden Labs

Organization & Developments: Leyden Labs

Parents

*Leyden Lab developing non-vaccine intranasal antibody programs to safeguard people from respiratory viruses based on Mucosal Protection Platform utilizing broadly protective antibodies.
*Leyden Labs is advancing a novel class of broadly protective nasal sprays, including its PanFlu candidate containing the monoclonal antibody CR9114 which is currently in development for influenza prophylaxis and initiation of human efficacy studies of PanFlu
Develop a portfolio of candidates aimed at providing protection against influenza, coronaviruses, and other respiratory viruses through a new class of broadly protective nasal sprays.